期刊文献+

糖代谢异常与肿瘤发生发展 被引量:2

下载PDF
导出
摘要 早在1959年.Joslin等就报道了肿瘤和糖尿病在同一患者出现的问题。但当时尚缺乏有力的证据。1960年,两者的联系在一人口普查时被再次提出:肿瘤更易出现在有糖尿病的患者。2009年12月,美国糖尿病学会和美国癌症协会联合发布了一项公告,即2型糖尿病(T2DM)与多种癌症的发生风险增高有关,且与无糖尿病的癌症患者相比,有糖尿病的癌症患者短期、长期病死率增加。由此关于糖尿病和癌症之间的关联性成为研究的热点。
作者 刘洋 许新华
出处 《实用医学杂志》 CAS 北大核心 2012年第22期3844-3846,共3页 The Journal of Practical Medicine
基金 湖北省卫生厅科研项目(编号:JX4B52) 2011年宜昌市科技研究与开发项目(编号:A11301-04) 2011年度湖北省自然科学基金项目(编号:2011CDB330)
  • 相关文献

参考文献4

二级参考文献81

  • 1王鹤,乔友林.老年恶性肿瘤流行病学、病因及预防[J].中华老年多器官疾病杂志,2005,4(3):170-172. 被引量:34
  • 2李英梅,夏稻子,马秀丽,刘聪.糖尿病患者胰腺的超声组织定征研究[J].中国医学影像技术,2006,22(3):436-438. 被引量:30
  • 3徐婷,颜勤明,徐丽伟.2型糖尿病患者血清CA19-9浓度的变化及其与血糖的相关性[J].实用医学杂志,2007,23(5):676-677. 被引量:21
  • 4Stovring H,Andersen M,Beck-Nielsen H,Green A,Vach W.Rising prevalence of diabetes:evidence from a Danish pharmaco-epidemiological database.Lancet 2003; 362:537-538.
  • 5Chauhan TS.Diabetes' rising toll.CMAJ 2003; 169:1068.
  • 6Hassan MM,Hwang LY,Hatten CJ,Swaim M,Li D,Abbruzzese JL,Beasley P,Patt YZ.Risk factors for hepatocellular carcinoma:synergism of alcohol with viral hepatitis and diabetes mellitus.Hepatology 2002; 36:1206-1213.
  • 7Wideroff L,Gridley G,Mellemkjaer L,Chow WH,Linet M,Keehn S,Borch-Johnsen K,Olsen JH.Cancer incidence in a population-based cohort of patients hospitalized with diabetes mellitus in Denmark.J Natl Cancer Inst 1997; 89:1360-1365.
  • 8El-Serag HB,Richardson PA,Everhart JE.The role of diabetes in hepatocellular carcinoma:a case-control study among United States Veterans.Am J Gastroenterol 2001; 96:2462-2467.
  • 9Calle EE,Murphy TK,Rodriguez C,Thun MJ,Heath CW Jr.Diabetes mellitus and pancreatic cancer mortality in a prospective cohort of United States adults.Cancer Causes Control 1998; 9:403-410.
  • 10Silverman DT.Risk factors for pancreatic cancer:a casecontrol study based on direct interviews.Teratog Carcinog Mutagen 2001; 21:7-25.

共引文献38

同被引文献43

  • 1Fu S W. Chen L, Man Y G. miRNA biomarkers in breast Cancer detection and management [J]. J. Canc- er,2011 (2) : 116 - 122.
  • 2Iorio M V, Croce C M. MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive review[J]. EMBO Mol. Med. ,2012,4 (3) : 143 - 159.
  • 3Gunter M J, Hoover D R, YU H, et al. Insulin, insu- lin - like growth factor - I, and risk of breast cancer in postmenopausal women[J]. J. Natl. Cancer Inst. , 2009,101 (1) :48 - 60.
  • 4Warburg O. On the origin of cancer cells[J].Sci- ence, 1956,123 (3191) :309 - 314.
  • 5Macheda M L, Rogers S, Best J D. Molecular and cellular regulation of glucose transporter (GLUT) proteins in cancer [J]. J. Cell Physiol. , 2005,202 (3) :654 - 662.
  • 6Adekola K, Rosen S T, Shanmugam M. Glucose transporters in cancer metabolism [J]. Curr. Opin. Oncol. ,2012,24(6) :650 - 654.
  • 7Lagos - Quintana M, Rauhut R, Meyer J, et al. New microRNAs from mouse and human [J]. RNA, 2003,9 (2): 175 - 179.
  • 8Lund E, Gtittinger S, Calado A, et al. Nuclear ex- port of microRNA precursors [J]. Science, 2004, 303 (5654) :95 - 98.
  • 9Ma L, Teruya - Feldstein J, Weinberg R A. Tumour invasion and metastasis initiated by microRNA - 10b in breast cancer[J]. Nature,2007,449(7163) : 682 - 688.
  • 10Biagioni F, Bossel Ben - Moshe N, Fontemaggi G, et al. The locus of microRNA - 10b : a critical tar- get for breast cancer insurgence and dissemination [J]. Cell Cycle,2013,12(15) :2371 - 2375.

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部